Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    Keywords: RECEPTOR ; APOPTOSIS ; CELLS ; EXPRESSION ; INHIBITOR ; tumor ; CELL ; FACTOR RECEPTOR ; Germany ; human ; IN-VIVO ; PATHWAY ; PATHWAYS ; DEATH ; GENE ; GENE-EXPRESSION ; PROTEIN ; transcription ; cell line ; LINES ; NF-KAPPA-B ; ACTIVATION ; COMPLEX ; LIGAND ; COMPLEXES ; TRANSCRIPTION FACTOR ; INDUCTION ; CONTRAST ; KERATINOCYTES ; SKIN ; CELL-LINES ; treatment ; TARGET ; gene expression ; resistance ; CD95 ligand ; CELL-DEATH ; CELL-LINE ; LINE ; MODULATION ; SIGNALING PATHWAY ; SIGNALING PATHWAYS ; HUMAN KERATINOCYTES ; RECRUITMENT ; sensitivity ; RECEPTORS ; cell lines ; TRAIL ; DISC ; SIGNALING COMPLEX ; inflammation ; HaCaT ; TRAIL-INDUCED APOPTOSIS ; APOPTOSIS-INDUCING LIGAND ; CASPASE-8 ACTIVATION ; signaling ; keratinocyte ; TARGET GENE ; BIOCHEMICAL-CHARACTERIZATION ; C-FLIP ; DOMAIN KINASE RIP ; GENE INDUCTION ; SIGNALING COMPLEXES ; TNF RECEPTOR
    Abstract: Human keratinocytes undergo apoptosis following treatment with tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) via surface-expressed TRAIL receptors 1 and 2. In addition, TRAIL triggers nonapoptotic signaling pathways including activation of the transcription factor NF-kappaB, in particular when TRAIL-induced apoptosis is blocked. The intracellular protein cFLIP(L) interferes with TRAIL-induced apoptosis at the death-inducing signaling complex (DISC) in many cell types. To study the role of cFLIP(L) in TRAIL signaling, we established stable HaCaT keratinocyte cell lines expressing varying levels of cFLIP(L). Functional analysis revealed that relative cFLIP(L) levels correlated with apoptosis resistance to TRAIL. Surprisingly, cFLIP(L) specifically blocked TRAIL-induced NF-kappaB activation and TRAIL-dependent induction of the proinflammatory target gene interleukin-8. Biochemical characterization of the signaling pathways involved showed that apoptosis signaling was inhibited at the DISC in cFLIP(L)-overexpressing keratinocytes, although cFLIP(L) did not significantly impair enzymatic activity of the receptor complex. In contrast, recruitment and modification of receptor-interacting protein was blocked in cFLIP(L)-overexpressing cells. Taken together, our data demonstrate that cFLIP(L) is not only a central antiapoptotic modulator of TRAIL-mediated apoptosis but also an inhibitor of TRAIL-induced NF-kappaB activation and subsequent proinflammatory target gene expression. Hence, cFLIP(L) modulation in keratinocytes may not only influence apoptosis sensitivity but may also lead to altered death receptor-dependent skin inflammation
    Type of Publication: Journal article published
    PubMed ID: 15459191
    Signatur Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...